📢 𝗥𝗲𝗮𝗹𝟰𝗥𝗲𝗴 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝗲𝗱! Our latest publication “𝗞𝗲𝘆 𝗦𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀’ 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲, 𝗢𝗽𝗶𝗻𝗶𝗼𝗻𝘀, 𝗮𝗻𝗱 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝘀 𝗼𝗻 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 – 𝗥𝗲𝘀𝘂𝗹𝘁𝘀 𝗼𝗳 𝗮𝗻 𝗘𝗨-𝗪𝗶𝗱𝗲 𝗦𝘂𝗿𝘃𝗲𝘆” was mentioned by The Evidence Base, as one of their December 2025 article picks.

📢 𝗡𝗲𝘄 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻!

📢 𝗡𝗲𝘄 𝗔𝗿𝘁𝗶𝗰𝗹𝗲 𝗶𝗻 𝗥𝗲𝗮𝗹𝟰𝗥𝗲𝗴 𝗪𝗲𝗯𝘀𝗶𝘁𝗲! Real4Reg recently published a new article about “𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗲𝗻𝗱𝗲𝗿 𝗚𝗮𝗽 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: 𝗧𝗵𝗲 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝘃𝗲 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗥𝗪𝗘 𝗮𝗻𝗱 𝗔𝗜 𝗳𝗼𝗿 𝗪𝗼𝗺𝗲𝗻'𝘀 𝗦𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀” on the website.

🌟 As 2025 comes to an end, the Real4Reg members would like to thank our followers for all the support given not only throughout the year, but also since the beginning of the project.

✍𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗻𝗼𝘄 𝗼𝗽𝗲𝗻! Real4Reg has the pleasure to announce our upcoming 𝗘𝘅𝗽𝗲𝗿𝘁𝘀 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 entitled “𝗥𝗲𝗮𝗹𝟰𝗥𝗲𝗴 𝗨𝘀𝗲 𝗖𝗮𝘀𝗲 𝟭 – 𝗟𝗲𝘀𝘀𝗼𝗻𝘀 𝗟𝗲𝗮𝗿𝗻𝗲𝗱 𝗼𝗻 𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗗𝗮𝘁𝗮”.

📢 𝗥𝗲𝗮𝗹𝟰𝗥𝗲𝗴 𝗮𝘁 𝘁𝗵𝗲 𝟮𝟮𝗻𝗱 𝗣𝗼𝗿𝘁𝘂𝗴𝘂𝗲𝘀𝗲 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀! On 26-28 November, the Portuguese Society of Oncology held the 22nd Portuguese Oncology Congress in Braga, Portugal.

🚨 𝗥𝗲𝗮𝗹𝟰𝗥𝗲𝗴 𝗮𝘁 𝘁𝗵𝗲 𝟭𝟳𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗡𝗼𝗿𝗣𝗘𝗡 𝗠𝗲𝗲𝘁𝗶𝗻𝗴! ℹ️ On 19-21 November, the Nordic Pharmacoepidemiological Network (NorPEN) held their annual meeting in Uppsala, Sweden and this year’s theme was “𝗡𝗼𝗿𝗱𝗶𝗰 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗲𝗽𝗶𝗱𝗲𝗺𝗶𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝗮 𝗴𝗹𝗼𝗯𝗮𝗹 𝘀𝗲𝘁𝘁𝗶𝗻𝗴”.

📢 𝗥𝗲𝗮𝗹𝟰𝗥𝗲𝗴 𝗮𝘁 𝘁𝗵𝗲 𝗥𝗪𝗘𝟰𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝟮𝟬𝟮𝟱! On 20 November, @RWE4Decisions held their annual online symposium and this year’s theme was “Mobilising Real-World-Data to Enhance HTA/Payer Decision-Making”.

📌 𝗟𝗮𝘀𝘁 𝟮𝟬𝟮𝟱 𝗖𝗼𝗻𝘀𝗼𝗿𝘁𝗶𝘂𝗺 𝗠𝗲𝗲𝘁𝗶𝗻𝗴! On 𝟭𝟳 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿, Real4Reg had the last Consortium Meeting of 2025.

📢 New Article in Real4Reg Website! Real4Reg recently published a new article regarding “Machine learning on sensitive data” on the website. It was written by our partners from @Finnish Center for Scientific Computing (#CSC). Here you will be able to find:

📢 New Real4Reg Newsletter! Real4Reg has recently launched its ninth newsletter. In this issue you will be able to find:

🎗️ In 2022, according to the World Health Organization (#WHO), breast cancer was the most common type of cancer in 157 of 185 countries. The most affected population were women, representing 99% of the cases, with 2.3 million diagnostics and 670 000 deaths.

📢Real4Reg at the GetReal Institute 2025 Annual Conference! On the first and second days of October, the GetReal Institute held their annual conference in Utrecht, Netherlands.

📢 Real4Reg at the 41st ICPE Annual Meeting! Last month, in Washington DC, USA, the 41st Annual Meeting of the International Society for Pharmacoepidemiology (#ISPE ) gathered global experts to discuss the latest advances in pharmacoepidemiology. Photo credit: Marietta Roth

📢 Interested in understanding how health data can support better care, inform decision-making, and shape public policies? umcgresearch.org/more-europa-... Our sister project in the #MetReal Cluster, #More-EUROPA, has developed a series of e-learning sessions.

🎯 Real4Reg at the EU HTA Conference #Real4Reg was presented at the conference "EU Health Technology Assessment: Advent of a New Era of Collaboration", held on 2 July in Brussels and organised by the European Comission @ec.europa.eu.

During the @eurodurg.bsky.social conference (July 1-4) in Uppsala, Sweden, our colleague Anne Paakinaho @uniuef.bsky.social presented the digital poster “Oral antibiotic use with focus on fluoroquinolones during 2010-2021 in 4European countries: Finnish 🇫🇮 results of the HORIZON-EU project Real4Reg"

Our hybrid meeting, hosted by @infarmed-ip.bsky.social, continues today with in-depth discussions and strategic planning for the next phases of the project.

📍 Real4Reg consortium meets in Lisbon! Today marks the first day of our annual hybrid consortium meeting, taking place in Lisbon on 21–22 May 2025, hosted by @INFARMED, I.P..

Stay Connected with Real4Reg updates and initiatives! 🔗 🚨Ensure you never miss out on the latest updates and insights by subscribing to our newsletter: www.real4reg.eu/news-events/...

The #Real4Reg project’s position paper introduces the project, outlining its structure, objectives, and key contributions within the broader landscape of #RWD -focused European projects and initiatives. Explore the full article here: health-policy-systems.biomedcentral.com/articles/10....

Multi-Stakeholder Workshop on RWD in regulatory & HTA decision-making in Bonn! Last month, we had a very fruitful hybrid workshop at #BfArM, bringing together a diverse group of stakeholders interested in real-world data (#RWD). Find out more on our website: www.real4reg.eu/news-events/...

Hot off the press: Part two of our pick of articles within HTA and RWE published in February 2025 | Becaris Publishing becarispublishing.com/digital-cont...

🚀 We’re now on Bluesky! Follow us for the latest updates on #Real4Reg - Unlocking #Real-World Data with #AI. Stay tuned for exciting insights and progress!